Matches in Nanopublications for { ?s ?p "[Monocytic MLL-AF9 expressing cells (MM6, THP-1) were hypersensitive to both small-molecule inhibitors targeting Rac1 (EHT 1864, NSC 23766) (IC50EHT�~12.5�?M) and lipid lowering drugs (lovastatin, atorvastatin) (IC50Lova�~7.5�?M) as compared to acute myelocytic leukemia (NOMO-1, HL60) and T cell leukemia (Jurkat) cells (IC50EHT�>30�?M; IC50Lova�>25�?M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP833650.RABQNmDYBT5lqGuotWHuVFw2EgmuumhwETeb3P3cvRP7U130_assertion description "[Monocytic MLL-AF9 expressing cells (MM6, THP-1) were hypersensitive to both small-molecule inhibitors targeting Rac1 (EHT 1864, NSC 23766) (IC50EHT�~12.5�?M) and lipid lowering drugs (lovastatin, atorvastatin) (IC50Lova�~7.5�?M) as compared to acute myelocytic leukemia (NOMO-1, HL60) and T cell leukemia (Jurkat) cells (IC50EHT�>30�?M; IC50Lova�>25�?M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP833650.RABQNmDYBT5lqGuotWHuVFw2EgmuumhwETeb3P3cvRP7U130_provenance.
- NP805167.RADcpRrB_gjGXGWgpHeYARm0_fJDjgCA0tzpdCkikt9_8130_assertion description "[Monocytic MLL-AF9 expressing cells (MM6, THP-1) were hypersensitive to both small-molecule inhibitors targeting Rac1 (EHT 1864, NSC 23766) (IC50EHT�~12.5�?M) and lipid lowering drugs (lovastatin, atorvastatin) (IC50Lova�~7.5�?M) as compared to acute myelocytic leukemia (NOMO-1, HL60) and T cell leukemia (Jurkat) cells (IC50EHT�>30�?M; IC50Lova�>25�?M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP805167.RADcpRrB_gjGXGWgpHeYARm0_fJDjgCA0tzpdCkikt9_8130_provenance.
- NP862532.RAcxat4QBdO6vLmqBXX9hzwm6CuDjWngLJ0imSxtdcPOs130_assertion description "[Monocytic MLL-AF9 expressing cells (MM6, THP-1) were hypersensitive to both small-molecule inhibitors targeting Rac1 (EHT 1864, NSC 23766) (IC50EHT�~12.5�?M) and lipid lowering drugs (lovastatin, atorvastatin) (IC50Lova�~7.5�?M) as compared to acute myelocytic leukemia (NOMO-1, HL60) and T cell leukemia (Jurkat) cells (IC50EHT�>30�?M; IC50Lova�>25�?M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862532.RAcxat4QBdO6vLmqBXX9hzwm6CuDjWngLJ0imSxtdcPOs130_provenance.
- NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_assertion description "[Monocytic MLL-AF9 expressing cells (MM6, THP-1) were hypersensitive to both small-molecule inhibitors targeting Rac1 (EHT 1864, NSC 23766) (IC50EHT�~12.5�?M) and lipid lowering drugs (lovastatin, atorvastatin) (IC50Lova�~7.5�?M) as compared to acute myelocytic leukemia (NOMO-1, HL60) and T cell leukemia (Jurkat) cells (IC50EHT�>30�?M; IC50Lova�>25�?M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_provenance.
- NP708288.RA26dngr2SrFqrzjiGw05hXmBNjChZiCBvPVvPcFwRyNc130_assertion description "[Monocytic MLL-AF9 expressing cells (MM6, THP-1) were hypersensitive to both small-molecule inhibitors targeting Rac1 (EHT 1864, NSC 23766) (IC50EHT�~12.5�?M) and lipid lowering drugs (lovastatin, atorvastatin) (IC50Lova�~7.5�?M) as compared to acute myelocytic leukemia (NOMO-1, HL60) and T cell leukemia (Jurkat) cells (IC50EHT�>30�?M; IC50Lova�>25�?M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP708288.RA26dngr2SrFqrzjiGw05hXmBNjChZiCBvPVvPcFwRyNc130_provenance.
- NP592872.RAOZ5H4Zza5HhV7Dwe0c8ieLQtweUrTXLDqp_c2PuknBU130_assertion description "[Monocytic MLL-AF9 expressing cells (MM6, THP-1) were hypersensitive to both small-molecule inhibitors targeting Rac1 (EHT 1864, NSC 23766) (IC50EHT�~12.5�?M) and lipid lowering drugs (lovastatin, atorvastatin) (IC50Lova�~7.5�?M) as compared to acute myelocytic leukemia (NOMO-1, HL60) and T cell leukemia (Jurkat) cells (IC50EHT�>30�?M; IC50Lova�>25�?M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP592872.RAOZ5H4Zza5HhV7Dwe0c8ieLQtweUrTXLDqp_c2PuknBU130_provenance.